GEZLID-60

Description

GEZLID-60 contains Gliclazide 60 mg in tablet form. Gliclazide belongs to the sulfonylurea class of oral antidiabetic medicines and helps lower blood glucose by stimulating the pancreas to release insulin. It may be prescribed for adults with type 2 diabetes mellitus when appropriate alongside dietary measures, physical activity and regular blood glucose monitoring.

For related diabetic and cardiovascular formulations, explore the Cardries Biotic range from Medhexa Pharma for pharmaceutical products and business enquiries.

Therapeutic Segment

Anti-Diabetic Therapy | Type 2 Diabetes Management | Sulfonylureas | Blood Glucose Control

Uses of GEZLID-60

GEZLID-60 may be prescribed as part of an individualized treatment plan for:

• Type 2 diabetes mellitus
• Inadequate blood glucose control with diet and exercise alone
• Patients requiring sulfonylurea therapy
• Improving glycaemic control when additional oral antidiabetic treatment is required
• Long-term blood glucose management under medical supervision

Gliclazide is intended for the management of type 2 diabetes and should be used together with appropriate dietary measures and physical activity.

It is not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

Key Benefits of GEZLID-60

• Blood Glucose Control: Helps lower elevated blood glucose levels in adults with type 2 diabetes.
• Sulfonylurea Action: Stimulates pancreatic beta cells to release insulin.
• 60 mg Strength: Provides Gliclazide 60 mg in a convenient oral tablet.
• Supports Glycaemic Management: May help improve blood glucose control when lifestyle measures alone do not provide adequate results.
• Individualized Diabetes Therapy: May be used alone or with other glucose-lowering medicines when clinically appropriate.
• Convenient Oral Formulation: Supplied as tablets for administration according to the prescribed regimen.

How GEZLID-60 Works

Gliclazide belongs to the sulfonylurea group of oral antidiabetic medicines.

It acts primarily on pancreatic beta cells by binding to sulfonylurea receptors. This action stimulates insulin secretion and helps lower blood glucose levels.

Gliclazide therefore supports the body’s insulin response and can improve glycaemic control in people with type 2 diabetes.

Because gliclazide stimulates insulin release, hypoglycaemia can occur, particularly when meals are skipped, food intake is inadequate, physical activity increases unexpectedly or the prescribed dose does not match the patient’s needs.

Common Side Effects of GEZLID-60

Some people may experience side effects while taking gliclazide. Possible effects include:

• Hypoglycaemia
• Nausea
• Indigestion
• Abdominal discomfort
• Diarrhoea or constipation
• Headache
• Dizziness
• Increased appetite
• Weight gain
• Skin rash

Hypoglycaemia may cause sweating, shaking, hunger, dizziness, weakness, confusion, difficulty concentrating or a rapid heartbeat.

Seek urgent medical attention if severe hypoglycaemia occurs, particularly if the person becomes unconscious or cannot safely take food or glucose.

Important Safety Information

Use GEZLID-60 only according to the advice of a qualified healthcare professional.

• Take gliclazide according to the prescribed schedule and maintain regular meals. Skipping meals can increase the risk of hypoglycaemia.
• Learn to recognize symptoms of low blood sugar, especially if GEZLID-60 is used with insulin or other glucose-lowering medicines.
• Do not take an additional tablet to compensate for a missed dose unless your healthcare professional specifically advises you to do so.
• Tell your doctor if you have kidney or liver disease, as these conditions may affect glucose control and the safety of sulfonylurea treatment.
• Inform your healthcare professional if you have experienced severe or recurrent hypoglycaemia.
• Increased physical activity, reduced food intake or significant dietary changes can alter blood glucose levels and may require treatment review.
• Alcohol can increase the risk of hypoglycaemia and may affect blood glucose control. Discuss alcohol use with your healthcare professional.
• Tell your doctor about all medicines you take, including other antidiabetic medicines, antibiotics, anticoagulants and over-the-counter products, because some medicines can alter blood glucose or gliclazide effects.
• Monitor blood glucose as recommended by your diabetes-care team.
• Discuss pregnancy and breastfeeding with your healthcare professional before using gliclazide.
• Do not change the dose or stop treatment without medical advice.
• Seek medical attention for severe allergic reactions, persistent vomiting, unusual weakness or other concerning symptoms.

For additional information about gliclazide, refer to the NHS guidance on gliclazide.

Dosage & Administration

Take GEZLID-60 exactly as prescribed by your healthcare professional.

The appropriate gliclazide dose depends on blood glucose levels, treatment response, age, kidney and liver function, diet and other medicines being used.

For 60 mg gliclazide modified-release formulations, the usual starting dose is commonly 30 mg once daily, with the dose adjusted according to blood glucose response and tolerability. A 60 mg strength may therefore represent an adjusted daily dose in appropriate patients.

However, because the exact release characteristics of the supplied product have not been specified, dosing should follow the approved product information and the prescription provided by the healthcare professional.

If GEZLID-60 is a modified-release formulation, swallow the tablet whole with water unless the product information specifically permits another method of administration. Do not crush or chew modified-release tablets.

Maintain regular meals during treatment because gliclazide can cause hypoglycaemia if insulin release exceeds the body’s glucose requirements.

If you miss a dose, follow your healthcare professional’s instructions rather than taking an extra tablet.

Storage

• Store in a cool, dry place.
• Protect the tablets from excessive heat and moisture.
• Keep the tablets in their original BLISTER packaging until use.
• Protect from direct sunlight.
• Keep out of the sight and reach of children.
• Do not use the product after the expiry date printed on the pack.